Intradialytic Exercise and Remote Ischaemic Preconditioning: a Cardioprotective Role ?

Last updated: February 27, 2025
Sponsor: University of Avignon
Overall Status: Active - Recruiting

Phase

N/A

Condition

Occlusions

Hemodialysis

Treatment

Remote ischaemic preconditioning

Exercise

standard dialysis

Clinical Study ID

NCT06856512
AU-092024-CM
LAPEC/2024/DIAL
  • Ages 20-79
  • All Genders

Study Summary

The aim of this clinical trial is to evaluate whether intermittent exercise and remote ischaemic preconditioning (rIPC) during haemodialysis (HD) can provide cardioprotection in adult patients (aged 20-79 years) undergoing HD for at least 3 months. The main questions to be answered are

Does intermittent exercise or rIPC reduce myocardial stunning during HD? Do these interventions have a beneficial effect on haemorheology, arrhythmias, systemic inflammation and HD efficiency? The investigators will compare three HD sessions: no intervention (HD-CONT), with moderate-intensity intermittent exercise (HD-EX), and with rIPC using cuff inflation (HD-rIPC) to see if HD6EX and HD-rIPC approaches offer enhanced cardioprotection.

Participants will:

Undergo three randomised HD sessions. Participate in 5 blocks of moderate-intensity exercise or rIPC during the HD sessions.

Have cardiac function and biomarkers assessed before, during and after HD.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients aged between 20 and 79 years.

  • Patients on hemodialysis for more than 3 months.

  • No engagement in regular exercise outside of dialysis.

  • No prior exposure to intradialytic exercise within the past six months.

  • No medical contraindications to physical activity.

  • Life expectancy greater than 6 months.

  • Patients with relative good echogenicity

Exclusion Criteria

  • Patient is participating in another Category I interventional study, or has participated in another interventional study within the past 3 months

  • The patient is in an exclusion period determined by a previous study

  • The patient is under legal protection or under guardianship or curatorship It turns out to be impossible to give the patient informed information, or the patient refuses to sign the consent

  • Pregnant, parturient or breastfeeding patient

  • Patients with unstable coronary artery disease.

  • Patients with peripheral artery disease (stage III or IV) in the lower limbs.

  • Patients with limb amputation.

  • Patients with musculoskeletal disorders impairing exercise.

  • Presence of a pacemaker, cardiac stimulation device, or implantable cardioverter defibrillator (ICD).

  • History of heart transplant.

  • Patients with uncontrolled hypertension.

  • Refractory anemia.

Study Design

Total Participants: 46
Treatment Group(s): 3
Primary Treatment: Remote ischaemic preconditioning
Phase:
Study Start date:
February 17, 2025
Estimated Completion Date:
November 30, 2025

Connect with a study center

  • Aider Sante

    Montpellier,
    France

    Site Not Available

  • Aider Sante

    Nimes,
    France

    Active - Recruiting

  • CHU Strasbourg

    Strasbourg,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.